Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.82 USD | -2.19% | +4.76% | -8.65% |
May. 10 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
May. 08 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.65% | 1.43B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- RBC Capital Adjusts Pacira BioSciences Price Target to $75 From $76, Maintains Outperform Rating